Patent ID: 8541449
Filing Date: 2013-09-24
Classification: A61P,C07D

Abstract:
1. A compound of the formula (I) wherein R R R R R R R R′, OH, halogen, (C O—(C (C (C (C (C (C (C (C (C (C (C (C (C COOH, C(O)O—(C C(O)OR′ C(O)(C C(O)R′, C(O)NH C(O)—NH—(C C(O)—NH—(C C(O)NH—(C C(O)NHR′, C(O)—NH(C C(O)N[(C C(O)N[(C C(O)—(C C(O)O(C R or is one (C or, if m; and s are 2, m is 3 and s is 1, or m is 4 and s is 0, R and, if m is 3 and s is 3, R wherein L can be bound to any secondary or tertiary carbon atom and wherein the bicyclic ring system or adamantane system is unsubstituted or optionally substituted by R R H, (C O—(C O—(C (C R H, (C (C (C (C (C (C or R R (C (C (C (C (C or R or R R H, R′, (C (C (C (C (C (C (C (C (C (C (C (C C(O)O—(C C(O)OR′, C(O)(C C(O)R′, C(O)NH—(C C(O)NHR′, C(O)N [(C C(O)N[(C C(O)—(C C(O)O(C R R n is 0, 1, 2, 3 or 4; m is 1, 2, 3 or 4; s is 0, 1, 2, or 3; r is 1 or 2; L is O(CH p is 0, 1, 2, 3 or 4; R′ is (C (C (C (C wherein in residues R wherein in residues R wherein in residues R wherein in residues R C(NH)(NH (C wherein said (C wherein (C wherein aryl substituents of (C their stereoisomeric and/or tautomeric forms or a pharmaceutically acceptable salt.